Retirement Systems of Alabama Reduces Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Retirement Systems of Alabama trimmed its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 112,812 shares of the company’s stock after selling 1,694 shares during the period. Retirement Systems of Alabama owned 0.12% of Acadia Healthcare worth $7,153,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ACHC. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares during the period. William Blair Investment Management LLC increased its holdings in Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter. State Street Corp raised its stake in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after acquiring an additional 95,613 shares during the period. Point72 Asset Management L.P. boosted its position in shares of Acadia Healthcare by 0.5% in the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after purchasing an additional 12,470 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Acadia Healthcare by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock worth $102,320,000 after purchasing an additional 14,197 shares in the last quarter.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $39.64 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The company’s 50-day moving average price is $44.78 and its 200-day moving average price is $61.40. The company has a market cap of $3.68 billion, a PE ratio of 13.00, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.91 earnings per share. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on ACHC. KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. Barclays cut their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Royal Bank of Canada dropped their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $75.44.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.